Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Migraine Topic Center

Conference Coverage
CGRP-targeting Monoclonal Antibodies Safe, Effective in Treatment of Migraine
07/14/2021
CGRP-targeting monoclonal antibodies can be a successful, safe option for migraine treatment, according to a recent presentation at Neurology Week.
CGRP-targeting monoclonal antibodies can be a successful, safe option for migraine treatment, according to a recent presentation at Neurology Week.
CGRP-targeting monoclonal...
07/14/2021
Neurology
News
Signs of Chronic Intracranial Hypertension on Magnetic Resonance Imaging Not Associated with Papilledema
05/17/2021
While magnetic resonance imaging (MRI) signs of chronic intracranial hypertension are common for patients undergoing brain assessments, they are rarely associated with papilledema.
While magnetic resonance imaging (MRI) signs of chronic intracranial hypertension are common for patients undergoing brain assessments, they are rarely associated with papilledema.
While magnetic resonance imaging...
05/17/2021
Neurology
News
Fremanezumab Yields Early Reductions in Headache Severity and Duration
04/26/2021
Fremanezumab treatment reduces headache severity and durations for patients with chronic migraine or episodic migraine, according to new findings presented at the American Academy of Neurology Annual Meeting.
Fremanezumab treatment reduces headache severity and durations for patients with chronic migraine or episodic migraine, according to new findings presented at the American Academy of Neurology Annual Meeting.
Fremanezumab treatment reduces...
04/26/2021
Neurology
Pop Quiz: Choosing Wisely With Headaches and Neuroimaging Studies
Quiz
Pop Quiz: Choosing Wisely With Headaches and Neuroimaging Studies
09/15/2020
Is the statement "Neuroimaging studies should be performed among patients with stable headaches that meet migraine criteria" true or false? Test your knowledge in our latest quiz!
Is the statement "Neuroimaging studies should be performed among patients with stable headaches that meet migraine criteria" true or false? Test your knowledge in our latest quiz!
Is the statement "Neuroimaging...
09/15/2020
Neurology
Quiz
Pop Quiz: Status Migrainosus
06/17/2020
How long must a migraine attack last for it to be considered status migrainosus? Test your knowledge in our latest quiz.
How long must a migraine attack last for it to be considered status migrainosus? Test your knowledge in our latest quiz.
How long must a migraine attack...
06/17/2020
Neurology
Poll
Poll: Optimization of Migraine Treatment
06/09/2020
In your practice, how do you ensure that treatment is optimized for your patients with migraine? Let us know by taking our poll.
In your practice, how do you ensure that treatment is optimized for your patients with migraine? Let us know by taking our poll.
In your practice, how do you...
06/09/2020
Neurology
News
Cluster Headache: What Role Does Family History Play?
04/29/2020
In a recent systematic review, researchers investigated the influence of inheritance patterns and family history rates in cluster headache. Here is what they found.
In a recent systematic review, researchers investigated the influence of inheritance patterns and family history rates in cluster headache. Here is what they found.
In a recent systematic review,...
04/29/2020
Neurology
News
Is Migraine Tied to Ischemic Stroke Among Women?
04/09/2020
The authors of a recent narrative review sought to identify factors that may be associated with an increased risk of stroke among women with migraine.
The authors of a recent narrative review sought to identify factors that may be associated with an increased risk of stroke among women with migraine.
The authors of a recent...
04/09/2020
Neurology
News
New Migraine Assessment Tool Is Reliable, Valid, and Responsive
03/20/2020
In a new study, researchers developed and validated a 25-item, disease-specific, patient-reported outcome measure for vestibular migraine.
In a new study, researchers developed and validated a 25-item, disease-specific, patient-reported outcome measure for vestibular migraine.
In a new study, researchers...
03/20/2020
Neurology
News
Study: Migraine Symptoms Improve With Weight Loss
02/11/2020
Can losing weight via bariatric surgery or behavioral intervention improve migraine frequency and indices of severity? Authors of a new study sought to find the answer. Read their results here.
Can losing weight via bariatric surgery or behavioral intervention improve migraine frequency and indices of severity? Authors of a new study sought to find the answer. Read their results here.
Can losing weight via bariatric...
02/11/2020
Neurology

Advertisement

Advertisement

News

Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology
A woman suffers from a migraine
News
Patients With Episodic Migraine 6 Time More Likely to Reduce Monthly Migraine Days With Erenumab
04/17/2024
Brionna Mendoza
In episodic migraine, patients treated with erenumab were 6 times more likely to achieve 50% or greater reduction in monthly migraine days, compared to ongoing treatment with nonspecific oral migraine preventive medications (OMPMs). Results...
In episodic migraine, patients treated with erenumab were 6 times more likely to achieve 50% or greater reduction in monthly migraine days, compared to ongoing treatment with nonspecific oral migraine preventive medications (OMPMs). Results...
In episodic migraine, patients...
04/17/2024
Neurology
Different Factors Found to Predict Morning and Later-Day Migraines
News
Different Factors Could Predict Morning and Later-Day Migraines
02/20/2024
Jolynn Tumolo
Poor perceived sleep and decreased energy the day before were each associated with increased risk of having a migraine in the morning. Researchers published the study results in Neurology. 
Poor perceived sleep and decreased energy the day before were each associated with increased risk of having a migraine in the morning. Researchers published the study results in Neurology. 
Poor perceived sleep and...
02/20/2024
Neurology
Secondhand Smoke Exposure Significantly Associated With Headache, Migraines
News
Secondhand Smoke Exposure Significantly Associated With Headache, Migraines
01/25/2024
Evi Arthur
Heavy secondhand smoke (SHS) exposure could increase risk of severe headaches or migraines in people who have never smoked, according to a cross-sectional study published in the journal Headache. 
Heavy secondhand smoke (SHS) exposure could increase risk of severe headaches or migraines in people who have never smoked, according to a cross-sectional study published in the journal Headache. 
Heavy secondhand smoke (SHS)...
01/25/2024
Neurology
News
Epilepsy, Migraine Drug Recalled
01/12/2024
Jolynn Tumolo
Azurity Pharmaceuticals Inc. is recalling 2220 bottles of Eprontia oral solution. According to the January 10, 2024, US Food and Drug Administration (FDA) Enforcement Report, samples of the drug tested out of specification for an impurity...
Azurity Pharmaceuticals Inc. is recalling 2220 bottles of Eprontia oral solution. According to the January 10, 2024, US Food and Drug Administration (FDA) Enforcement Report, samples of the drug tested out of specification for an impurity...
Azurity Pharmaceuticals Inc. is...
01/12/2024
Pharmacy Learning Network
A woman holds her forehead in pain with a migraine while talking to a doctor
News
Novel Migraine Pathways Could Guide Drug Development
11/28/2023
Jolynn Tumolo
An analysis of genetic data from more than 1.3 million people has revealed new biological pathways associated with migraine that could potentially be targeted for drug development.
An analysis of genetic data from more than 1.3 million people has revealed new biological pathways associated with migraine that could potentially be targeted for drug development.
An analysis of genetic data from...
11/28/2023
Neurology
Peripheral Auditory Deficits More Likely in Patients With Migraine, Parkinson, Multiple Sclerosis
News
Peripheral Auditory Deficits More Likely in Patients With Migraine, Parkinson, Multiple Sclerosis
09/18/2023
Jolynn Tumolo
The risk of peripheral auditory deficits are higher in patients with migraine/headache disorders, Parkinson disease, and multiple sclerosis than in healthy individuals, according to a systematic review published in Frontiers in Neurology. 
The risk of peripheral auditory deficits are higher in patients with migraine/headache disorders, Parkinson disease, and multiple sclerosis than in healthy individuals, according to a systematic review published in Frontiers in Neurology. 
The risk of peripheral auditory...
09/18/2023
Neurology
Young woman sitting in window holding head
News
Researchers Urge for New Menstrual Migraine Diagnostic Criteria
06/09/2023
Evi Arthur
Menstrual migraine (MM) was found to have different clinical characteristics than non-menstrual migraine (non-MM), indicating a need to revisit diagnostic criteria, according to a recent case-control study published in JAMA Network Open.
Menstrual migraine (MM) was found to have different clinical characteristics than non-menstrual migraine (non-MM), indicating a need to revisit diagnostic criteria, according to a recent case-control study published in JAMA Network Open.
Menstrual migraine (MM) was...
06/09/2023
Neurology
A middle-aged man wearing glasses sits holding his temple with migraine pain
News
As-Needed Intranasal Ketamine Relieves Refractory Migraine Pain in Some Patients
06/05/2023
Jolynn Tumolo
Nearly half of patients with refractory chronic migraine interviewed about their use of intranasal ketamine considered the treatment “very effective,” and more than two-thirds said it improved their quality of life.
Nearly half of patients with refractory chronic migraine interviewed about their use of intranasal ketamine considered the treatment “very effective,” and more than two-thirds said it improved their quality of life.
Nearly half of patients with...
06/05/2023
Neurology
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement